Journal of Risk and Uncertainty

, Volume 51, Issue 1, pp 1–21 | Cite as

Valuing gains in life expectancy: Clarifying some ambiguities

  • Michael Jones-Lee
  • Susan Chilton
  • Hugh Metcalf
  • Jytte Seested Nielsen
Article

Abstract

It is well-understood that a given gain in life expectancy can, in principle, be generated by any one of an infinite number of different types of perturbation in an individual’s survival function. Since it seems unlikely that the typical individual will be indifferent between these various types of perturbation, the idea that there exists a unique willingness to pay-based Value of a Statistical Life Year (VSLY), even for individuals within a given age-group, appears to be ill-founded. This paper examines the issue from a theoretical perspective. Within the context of a simple multi-period model it transpires that if gains in life expectancy are computed on an undiscounted basis then it will indeed be necessary to adjust the magnitude of the VSLY to accommodate the nature of the perturbation in the survival function, as well as the age of those affected. If, by contrast, gains in life expectancy are computed on an appropriately discounted basis then a unique VSLY will be applicable in all cases.

Keywords

Valuing gains in life expectancy VSLY VSL 

JEL Classification

J17 

References

  1. Aldy, J. E., & Viscusi, W. K. (2007). Age differences in the value of statistical life: Revealed preference evidence. Review of Environmental Economics and Policy, 1(2), 241–260.Google Scholar
  2. Aldy, J. E., & Viscusi, W. K. (2008). Adjusting the value of a statistical life for age and cohort effects. Review of Economics and Statistics, 90(3), 573–581.CrossRefGoogle Scholar
  3. Blomqvist, A. (2002). Defining the value of a statistical life: A comment. Journal of Health Economics, 21, 169–175.CrossRefGoogle Scholar
  4. Cairns, J. A., & van der Pol, M. M. (2000). The estimation of marginal time preference in a UK-wide sample (TEMPUS) project. Health Technology Assessment, 4(1), 1–83.Google Scholar
  5. Chapman, G. B. (1996). Temporal discounting and utility for health and money. Journal of Experimental Psychology. Learning, Memory, and Cognition, 22(3), 771–791.CrossRefGoogle Scholar
  6. Cropper, M. L., Aydede, S. K., & Portney, P. R. (1994). Preferences for life saving programs: How the public discounts time and age. Journal of Risk and Uncertainty, 8(3), 243–265.CrossRefGoogle Scholar
  7. Gold, M. R., Siegel, M. E., Russell, L. B., & Weinstein, M. C. (1996). Cost-effectiveness in health and medicine. New York: Oxford University Press.Google Scholar
  8. Gyrd-Hansen, D., & Sogaard, J. (1998). Discounting life-years: Whither time preference? Health Economics, 7, 121–127.CrossRefGoogle Scholar
  9. Hammitt, J. K. (2007). Valuing changes in mortality risk: Lives saved versus life years saved. Review of Environmental Economics and Policy, 1(2), 228–240.CrossRefGoogle Scholar
  10. Hammitt, J. K. (2013). Admissible utility functions for health, longevity, and wealth: Integrating monetary and life-year measures. Journal of Risk and Uncertainty, 47(3), 311–325.CrossRefGoogle Scholar
  11. Hammitt, J. K., & Haninger, K. (2010). Valuing fatal risks to children and adults: Effects of disease, latency and risk aversion. Journal of Risk and Uncertainty, 40(1), 57–83.CrossRefGoogle Scholar
  12. Hammitt, J. K., & Tunçel, T. (2015). Preferences for life-expectancy gains: Sooner or later? Journal of Risk and Uncertainty, 51(1), current issue.Google Scholar
  13. Hirth, R. A., Chernew, M. E., Miller, E., Fendrick, M., & Weissert, W. G. (2000). Willingness to pay for a quality-adjusted life year: In search of a standard. Medical Decision Making, 20, 332–342.CrossRefGoogle Scholar
  14. HM Treasury (2003). The green book: Appraisal and evaluation in central government. London: The Stationery Office.Google Scholar
  15. Hurley, J. F., Holland, M. R., Markandya, A., & Miller, B. G. (2000). Towards assessing and costing the health impacts of ambient particulate Air pollution in the UK. Edinburgh: Institute of Occupational Medicine Report. TM/00/007.Google Scholar
  16. Jenkins, S. P. (2005). Survival Analysis. University of Essex. Available at: www.iser.essex.ac.uk/survival-analysis.
  17. Johansson, P-O. (1996). On the value of changes in life expectancy. Journal of Health Economics, 15, 105–113.CrossRefGoogle Scholar
  18. Johansson, P-O. (2001). Is there a meaningful definition of the value of a statistical life? Journal of Health Economics, 20, 131–139.CrossRefGoogle Scholar
  19. Johannesson, M., Johansson, P-O., & Lofgren, K.-G. (1997). On the value of changes in life expectancy: Blips versus parametric changes. Journal of Risk and Uncertainty, 15, 221–239.CrossRefGoogle Scholar
  20. Jones-Lee, M. W. (1989). The economics of safety and physical risk. Oxford: Basil Blackwell.Google Scholar
  21. Khwaja, A., Silverman, D., & Sloan, F. (2007). Time preference, time discounting and smoking decisions. Journal of Health Economics, 26(5), 92–949.CrossRefGoogle Scholar
  22. Mason, H., Jones-Lee, M., & Donaldson, C. (2009). Modelling the monetary value of a QALY: A new approach based on UK data. Health Economics, 18, 933–950.CrossRefGoogle Scholar
  23. McDonald, R. L., Chilton, S. M., Jones-Lee, M. W., & Metcalf, H. R. T. (2016). Dread and latency impacts on a VSL for cancer risk reduction. Journal of Risk and Uncertainty, forthcoming. Google Scholar
  24. Moore, M. J., & Viscusi, W. K. (1988). The quantity-adjusted value of life. Economic Inquiry, 26(3), 369–388.CrossRefGoogle Scholar
  25. Nielsen, J. S., Chilton, S., Jones-Lee, M., & Metcalf, H. (2010). How would you like your gain in life expectancy to be provided? An experimental approach. Journal of Risk and Uncertainty, 41(3), 195–218.CrossRefGoogle Scholar
  26. NICE. (2011). Discounting for health benefits in special circumstances. PDF.Google Scholar
  27. OECD. (2010). Valuing environment-related health impacts – with special emphasis on children (VERHI – children), final report. Paris: OECD Publishing.Google Scholar
  28. OECD. (2012). Mortality risk valuation in environment, health and transport policies. Paris: OECD Publishing.Google Scholar
  29. Office for National Statistics. (2013). Interim life tables, England, 2009–2011, www.ons.gov.uk.
  30. Pliskin, J. S., Shepard, D. S., & Weinstein, M. C. (1980). Utility functions for life years and health status. Operations Research, 28, 206–224.CrossRefGoogle Scholar
  31. Pope, C. A., Thun, M. J., Namboodiri, M. M., Dockery, D. W., Evans, J. S., Speizer, F. E., & Heath Jr., C. W. (1995). Particulate air pollution as a predictor of mortality in a prospective study of US adults. American Journal of Respiratory and Critical Care Medicine, 151, 669–674.CrossRefGoogle Scholar
  32. Rosen, S. (1988). The value of changes in life expectancy. Journal of Risk and Uncertainty, 1, 285–304.CrossRefGoogle Scholar
  33. UK Inter-departmental group on valuation of life and health. (2010). Draft Green Book Supplementary Guidance. PDF.Google Scholar
  34. US EPA. (2003). Children’s health valuation handbook US. Washington, DC: EPA.Google Scholar
  35. Viscusi, W. K. (1998). Rational risk policy. Oxford: Oxford University Press.CrossRefGoogle Scholar
  36. Viscusi, W. K., Hakes, J. K., & Carlin, A. (1997). Measures of mortality risks. Journal of Risk and Uncertainty, 14, 213–233.CrossRefGoogle Scholar
  37. Viscusi, W. K., & Aldy, J. E. (2003). The value of a statistical life: A critical review of market estimates throughout the world. Journal of Risk and Uncertainty, 27(6), 5–76.CrossRefGoogle Scholar
  38. Wetterstrand, W. H. (1981). Parametric models for life insurance mortality data: Gompertz’s Law over time. Transactions of the Society of Actuaries, 33, 159–175.Google Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Michael Jones-Lee
    • 1
  • Susan Chilton
    • 1
  • Hugh Metcalf
    • 1
  • Jytte Seested Nielsen
    • 1
  1. 1.Newcastle University Business SchoolNewcastle upon TyneUK

Personalised recommendations